Stock Update (NYSE:PFE): Pfizer Announces Submission of Palbociclib New Drug Application to the FDA

[Business Wire] – Pfizer Inc. today announced it has completed the submission of a New Drug Application to the United States Food and Drug Administration for palbociclib. This NDA requests FDA approval of . . . → Read More: Stock Update (NYSE:PFE): Pfizer Announces Submission of Palbociclib New Drug Application to the FDA Similar Articles: Pfizer Inc (NYSE:PFE) – French biotech Cellectis surges as Pfizer signs cancer drug deal Market Update: Pfizer Inc (NYSE:PFE) – AstraZeneca in partnering talks for Alzheimer’s drug Merck & Co. Inc. (NYSE:MRK) – 8:31 am Merck initiates rolling submission of U.S. Biologics License Application for MK-3475, an investigational Anti-PD-1 Immunotherapy, in patients with advanced melanoma; expects to complete application in 1H14